These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9582015

  • 1. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer.
    Erber R, Conradt C, Homann N, Enders C, Finckh M, Dietz A, Weidauer H, Bosch FX.
    Oncogene; 1998 Apr 02; 16(13):1671-9. PubMed ID: 9582015
    [Abstract] [Full Text] [Related]

  • 2. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
    Leng K, Schlien S, Bosch FX.
    J Oral Pathol Med; 2006 Jan 02; 35(1):19-24. PubMed ID: 16393249
    [Abstract] [Full Text] [Related]

  • 3. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 4. Clinical implications of p53 mutation analysis in bladder cancer tissue and urine sediment by functional assay in yeast.
    Schlichtholz B, Presler M, Matuszewski M.
    Carcinogenesis; 2004 Dec 14; 25(12):2319-23. PubMed ID: 15308588
    [Abstract] [Full Text] [Related]

  • 5. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
    Kropveld A, Rozemuller EH, Leppers FG, Scheidel KC, de Weger RA, Koole R, Hordijk GJ, Slootweg PJ, Tilanus MG.
    Lab Invest; 1999 Mar 14; 79(3):347-53. PubMed ID: 10092071
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.
    Lindenbergh-van der Plas M, Brakenhoff RH, Kuik DJ, Buijze M, Bloemena E, Snijders PJ, Leemans CR, Braakhuis BJ.
    Clin Cancer Res; 2011 Jun 01; 17(11):3733-41. PubMed ID: 21467160
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
    Ganly I, Soutar DS, Brown R, Kaye SB.
    Br J Cancer; 2000 Jan 01; 82(2):392-8. PubMed ID: 10646894
    [Abstract] [Full Text] [Related]

  • 11. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T, Tokuchi Y, Hayashi M, Kobayashi Y, Nishida K, Hayashi S, Ishikawa Y, Tsuchiya S, Nakagawa K, Hayashi J, Tsuchiya E.
    Cancer Res; 1999 Nov 01; 59(21):5572-7. PubMed ID: 10554037
    [Abstract] [Full Text] [Related]

  • 12. Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.
    Yamazaki Y, Chiba I, Hirai A, Notani K, Kashiwazaki H, Tei K, Totsuka Y, Iizuka T, Kohgo T, Fukuda H.
    Am J Clin Oncol; 2003 Oct 01; 26(5):e124-9. PubMed ID: 14528086
    [Abstract] [Full Text] [Related]

  • 13. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
    Yarbrough WG.
    Laryngoscope; 2002 Dec 01; 112(12):2114-28. PubMed ID: 12461329
    [Abstract] [Full Text] [Related]

  • 14. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, Leemans R, van der Waal I, Snow GB, Brakenhoff RH.
    J Pathol; 2002 Dec 01; 198(4):476-86. PubMed ID: 12434417
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
    Homann N, Nees M, Conradt C, Dietz A, Weidauer H, Maier H, Bosch FX.
    Clin Cancer Res; 2001 Feb 01; 7(2):290-6. PubMed ID: 11234882
    [Abstract] [Full Text] [Related]

  • 16. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J.
    Acta Oncol; 2008 Feb 01; 47(4):600-7. PubMed ID: 18465328
    [Abstract] [Full Text] [Related]

  • 17. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
    Karsai S, Abel U, Roesch-Ely M, Affolter A, Hofele C, Joos S, Plinkert PK, Bosch FX.
    J Pathol; 2007 Feb 01; 211(3):314-22. PubMed ID: 17152048
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC, Lin JK, Lin TC, Liang WY.
    Int J Oncol; 2005 Jan 01; 26(1):65-75. PubMed ID: 15586226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.